Planta Med 2014; 80(07): 599-603
DOI: 10.1055/s-0034-1368349
Natural Product Chemistry
Original Papers
Georg Thieme Verlag KG Stuttgart · New York

Antiplasmodial and Antioxidant Isoquinoline Alkaloids from Dehaasia longipedicellata

Azeana Zahari
1   Department of Chemistry, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia
,
Foo Kit Cheah
4   Department of Pharmacy, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
,
Jamaludin Mohamad
2   Institute of Biological Sciences, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia
,
Syazreen Nadia Sulaiman
1   Department of Chemistry, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia
,
Marc Litaudon
3   Institut de Chimie des Substances Naturelles, Centre National de la Recherche Scientifique, Gif-sur Yvette, France
,
Kok Hoong Leong
4   Department of Pharmacy, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
,
Khalijah Awang
1   Department of Chemistry, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia
› Author Affiliations
Further Information

Publication History

received 22 September 2013
revised 28 February 2014

accepted 03 March 2014

Publication Date:
10 April 2014 (online)

Preview

Abstract

The crude extract of the bark of Dehaasia longipedicellata exhibited antiplasmodial activity against the growth of Plasmodium falciparum K1 isolate (resistant strain). Phytochemical studies of the extract led to the isolation of six alkaloids: two morphinandienones, (+)-sebiferine (1) and (−)-milonine (2); two aporphines, (−)-boldine (3) and (−)-norboldine (4); one benzlyisoquinoline, (−)-reticuline (5); and one bisbenzylisoquinoline, (−)-O-O-dimethylgrisabine (6). Their structures were determined on the basis of 1D and 2D NMR, IR, UV, and LCMS spectroscopic techniques and upon comparison with literature values. Antiplasmodial activity was determined for all of the isolated compounds. They showed potent to moderate activity with IC50 values ranging from 0.031 to 30.40 µM. (−)-O-O-dimethylgrisabine (6) and (−)-milonine (2) were the two most potent compounds, with IC50 values of 0.031 and 0.097 µM, respectively, that were comparable to the standard, chloroquine (0.090 µM). The compounds were also assessed for their antioxidant activities with di(phenyl)-(2,4,6-trinitrophenyl)iminoazanium (IC50 = 18.40–107.31 µg/mL), reducing power (27.40–87.40 %), and metal chelating (IC50 = 64.30 to 257.22 µg/mL) having good to low activity. (−)-O-O-dimethylgrisabine (6) exhibited a potent antioxidant activity of 44.3 % reducing power, while di(phenyl)-(2,4,6-trinitrophenyl)iminoazanium and metal chelating activities had IC50 values of 18.38 and 64.30 µg/mL, respectively. Thus it may be considered as a good reductant with the ability to chelate metal and prevent pro-oxidant activity. In addition to the antiplasmodial and antioxidant activities, the isolated compounds were also tested for their cytotoxicity against a few cancer and normal cell lines. (−)-Norboldine (4) exhibited potent cytotoxicity towards pancreatic cancer cell line BxPC-3 with an IC50 value of 27.060 ± 1.037 µM, and all alkaloids showed no toxicity towards the normal pancreatic cell line (hTERT-HPNE).